Varicella‐zoster virus immune evasion
- 28 April 1999
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 168 (1) , 143-156
- https://doi.org/10.1111/j.1600-065x.1999.tb01289.x
Abstract
Summary: CD4+ and CD8+ T cells play dual roles in varicella‐zoster virus (VZV) pathogenesis. The first role is to deliver the virus to cutaneous sites during primary VZV infection, permitting replication at these sites and the successful transmission of the virus to other susceptible individuals. The second contribution of T cells is to provide the critical antigen‐specific adaptive immunity needed to stop viral replication and maintain VZV latency in sensory ganglia. The equilibrium between VZV and the host can be predicted co be served by immune evasion mechanisms in at least two important ways, including the facilitation of cell‐associated viremia during primary VZV infection and silent persistence in dorsal root ganglia. Interference with antigen presentation by MHC class I downregulation may be expected to play a role in both circumstances. Transient interference with MHG class II expression in varicella skin lesions should facilitate local replication and transmission. In addition, when VZV reactivates, the capacity of viral gene produces to block the upregulation of MHC class II expression triggered by interferon‐y should permit a sufficient period of viral replication to cause the lesions of herpes zoster, despite the presence of VZV‐specific T cells, and to allow transmission of the virus to susceptible individuals. Although the effort is at an early stage compared to studies of other viral pathogens, identifying the VZV gene products that exert these effects and their mechanisms of interference has the potential to reveal novel aspects of MHG class I and class II antigen processing and presentation.Keywords
This publication has 135 references indexed in Scilit:
- The Human Cytomegalovirus US11 Gene Product Dislocates MHC Class I Heavy Chains from the Endoplasmic Reticulum to the CytosolCell, 1996
- Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccineThe Journal of Pediatrics, 1995
- Distribution of varicella‐zoster virus gpI and gpII and corresponding genome sequences in the skinJournal of Medical Virology, 1995
- Use of irradiated lymphocytes from immune donors for treatment of disseminated varicellaThe Journal of Pediatrics, 1994
- Varicella-Zoster Virus-Specific HLA-Restricted Cytotoxicity of Normal Immune Adult Lymphocytes After in Vitro StimulationThe Journal of Infectious Diseases, 1988
- The Complete DNA Sequence of Varicella-Zoster VirusJournal of General Virology, 1986
- Early Immune Response in Healthy and Immunocompromised Subjects with Primary Varicella-Zoster Virus InfectionThe Journal of Infectious Diseases, 1986
- Viremic phase in nonimmunocompromised children with varicellaThe Journal of Pediatrics, 1984
- Human Leukocyte Interferon for the Treatment of Varicella in Children with CancerNew England Journal of Medicine, 1982
- Cell-mediated immunity to varicella-zoster virus infection in subjects with lymphoma or leukemiaThe Journal of Pediatrics, 1979